• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将肠道微生物群调节作为对抗肥胖的精准策略

Using Gut Microbiota Modulation as a Precision Strategy Against Obesity.

作者信息

Baek Kwang-Rim, Singh Saloni, Hwang Hye-Seon, Seo Seung-Oh

机构信息

Department of Food Science and Biotechnology, Seoul National University of Science and Technology, Seoul 01811, Republic of Korea.

Research Institute of Food and Biotechnology, Seoul National University of Science and Technology, Seoul 01811, Republic of Korea.

出版信息

Int J Mol Sci. 2025 Jun 29;26(13):6282. doi: 10.3390/ijms26136282.

DOI:10.3390/ijms26136282
PMID:40650060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12249903/
Abstract

Obesity is a complex metabolic disorder with high global prevalence. Recent studies have highlighted the crucial role of gut microbiota in obesity's onset and progression. This review explores the relationship between gut microbiota composition and obesity, emphasizing how changes in microbial communities can influence host metabolism, energy balance, and fat storage. By reviewing current evidence regarding the interactions between specific microbial taxa; their metabolic byproducts, such as short-chain fatty acids; and host signaling pathways, we aim to clarify the mechanisms through which the gut microbiome contributes to obesity. Furthermore, we discuss the potential of microbiota engineering through precision strategies such as the use of probiotics, prebiotics, and genetically engineered microbial strains. Collectively, this review highlights the targeted modulation of the gut microbiome as a promising and innovative approach to the prevention and treatment of obesity.

摘要

肥胖是一种全球患病率很高的复杂代谢紊乱疾病。最近的研究强调了肠道微生物群在肥胖发生和发展中的关键作用。这篇综述探讨了肠道微生物群组成与肥胖之间的关系,着重阐述了微生物群落的变化如何影响宿主代谢、能量平衡和脂肪储存。通过回顾有关特定微生物分类群之间相互作用、它们的代谢副产物(如短链脂肪酸)以及宿主信号通路的现有证据,我们旨在阐明肠道微生物群导致肥胖的机制。此外,我们还讨论了通过精准策略(如使用益生菌、益生元及基因工程微生物菌株)进行微生物群工程改造的潜力。总的来说,这篇综述强调了对肠道微生物群进行靶向调节是预防和治疗肥胖的一种有前景的创新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d5/12249903/9a5e47c6b97e/ijms-26-06282-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d5/12249903/22207eeba45e/ijms-26-06282-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d5/12249903/9a5e47c6b97e/ijms-26-06282-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d5/12249903/22207eeba45e/ijms-26-06282-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73d5/12249903/9a5e47c6b97e/ijms-26-06282-g002.jpg

相似文献

1
Using Gut Microbiota Modulation as a Precision Strategy Against Obesity.将肠道微生物群调节作为对抗肥胖的精准策略
Int J Mol Sci. 2025 Jun 29;26(13):6282. doi: 10.3390/ijms26136282.
2
Gut microbiome-based interventions for the management of obesity in children and adolescents aged up to 19 years.基于肠道微生物群的干预措施用于管理19岁及以下儿童和青少年的肥胖问题。
Cochrane Database Syst Rev. 2025 Jul 10;7(7):CD015875. doi: 10.1002/14651858.CD015875.
3
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
4
Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities.肠道微生物群在导致体重紊乱及相关合并症中的作用。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0004523. doi: 10.1128/cmr.00045-23. Epub 2024 Jun 28.
5
Exploring the gut microbiome's influence on cancer-associated anemia: Mechanisms, clinical challenges, and innovative therapies.探索肠道微生物群对癌症相关性贫血的影响:机制、临床挑战及创新疗法。
World J Gastrointest Pharmacol Ther. 2025 Jun 5;16(2):105375. doi: 10.4292/wjgpt.v16.i2.105375.
6
The interplay of gut microbiota and intestinal motility in gastrointestinal function.肠道微生物群与肠道动力在胃肠功能中的相互作用。
J Smooth Muscle Res. 2025;61:51-58. doi: 10.1540/jsmr.61.51.
7
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
8
The gut microbiota in menopause: Is there a role for prebiotic and probiotic solutions?更年期的肠道微生物群:益生元和益生菌解决方案能发挥作用吗?
Post Reprod Health. 2025 May 7:20533691251340491. doi: 10.1177/20533691251340491.
9
Modulation of Gut Microbial Composition by subsp. CKDB001 Supplementation in a High-Fat-Diet-Induced Obese Mice.在高脂饮食诱导的肥胖小鼠中,补充副干酪乳杆菌亚种CKDB001对肠道微生物组成的调节作用
Nutrients. 2025 Jul 7;17(13):2251. doi: 10.3390/nu17132251.
10
Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes.运动诱发的应激行为、肠道微生物群-脑轴与饮食:运动员的系统综述。
J Int Soc Sports Nutr. 2016 Nov 24;13:43. doi: 10.1186/s12970-016-0155-6. eCollection 2016.

引用本文的文献

1
The effect of probiotics on weight management in patients with severe obesity undergoing metabolic and bariatric surgery: a systematic review and meta-analysis.益生菌对接受代谢和减重手术的重度肥胖患者体重管理的影响:一项系统评价和荟萃分析。
Ann Med. 2025 Dec;57(1):2551284. doi: 10.1080/07853890.2025.2551284. Epub 2025 Aug 24.

本文引用的文献

1
Gut microbiome and obesity in late adolescence: A case-control study in "Children of 1997" birth cohort.青春期后期的肠道微生物群与肥胖:一项针对“1997年出生队列儿童”的病例对照研究。
Ann Epidemiol. 2025 Jan;101:58-66. doi: 10.1016/j.annepidem.2024.12.009. Epub 2024 Dec 20.
2
Lactobacillus paragasseri SBT2055 attenuates obesity via the adipose tissue-muscle-gut axis in obese mice.副干酪乳杆菌SBT2055通过肥胖小鼠的脂肪组织-肌肉-肠道轴减轻肥胖。
Microbiol Res. 2025 Jan;290:127972. doi: 10.1016/j.micres.2024.127972. Epub 2024 Nov 14.
3
Composition of gut microbiota in obese and normal-weight Uygur adults and its association with adipocyte-related factors.
肥胖和正常体重维吾尔族成年人肠道微生物组成及其与脂肪细胞相关因素的关系。
Sci Rep. 2024 Oct 20;14(1):24649. doi: 10.1038/s41598-024-76351-8.
4
Gut microbiome diversity within is negatively associated with human obesity.肠道微生物多样性与人体肥胖呈负相关。
mSystems. 2024 Aug 20;9(8):e0062724. doi: 10.1128/msystems.00627-24. Epub 2024 Jul 16.
5
Fecal microbiota transplantation ameliorates abdominal obesity through inhibiting microbiota-mediated intestinal barrier damage and inflammation in mice.粪便微生物群移植通过抑制微生物群介导的肠道屏障损伤和炎症来改善小鼠腹部肥胖。
Microbiol Res. 2024 May;282:127654. doi: 10.1016/j.micres.2024.127654. Epub 2024 Feb 20.
6
Fecal microbiota transplantation in obesity metabolism: A meta analysis and systematic review.粪便微生物群移植在肥胖代谢中的作用:荟萃分析和系统评价。
Diabetes Res Clin Pract. 2023 Aug;202:110803. doi: 10.1016/j.diabres.2023.110803. Epub 2023 Jun 24.
7
Soy yoghurts produced with efficient GABA (γ-aminobutyric acid)-producing ameliorate hyperglycaemia and re-establish gut microbiota in streptozotocin (STZ)-induced diabetic mice.用高效产生γ-氨基丁酸(GABA)的方法生产的大豆酸奶可改善链脲佐菌素(STZ)诱导的糖尿病小鼠的高血糖症并重建肠道微生物群。
Food Funct. 2023 Feb 6;14(3):1699-1709. doi: 10.1039/d2fo02708a.
8
Effectiveness of Fecal Microbiota Transplantation for Weight Loss in Patients With Obesity Undergoing Bariatric Surgery: A Randomized Clinical Trial.粪便微生物群移植在肥胖症患者减重中的有效性:一项随机临床试验。
JAMA Netw Open. 2022 Dec 1;5(12):e2247226. doi: 10.1001/jamanetworkopen.2022.47226.
9
Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion.低聚果糖通过改变肠道微生物群、肠黏液产生、糖基化和分泌来预防高脂肪饮食诱导的肥胖。
Gut Microbes. 2022 Jan-Dec;14(1):2152307. doi: 10.1080/19490976.2022.2152307.
10
Postbiotics Prepared Using CCFM1224 Prevent Nonalcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Liver Metabolism.后生元 CCFM1224 通过调节肠道微生物群和肝脏代谢预防非酒精性脂肪肝疾病。
Int J Mol Sci. 2022 Nov 4;23(21):13522. doi: 10.3390/ijms232113522.